Expression of selected cytochrome P450 isoforms and of cooperating enzymes in colorectal tissues in selected pathological conditions

Pathology Research and Practice

Volumn 210, Issue 4, 2014, Pages 242-249

  Plewka, Danuta ^a   Plewka, Andrzej ^a   Szczepanik, Tomasz ^a   Morek, Michał ^a   Bogunia, Edyta ^a   Wittek, Piotr ^a   Kijonka, Czarosław ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Colorectal tissues; Crohn's disease; Cytochrome P450; Ulcerative colitis

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 2B6; CYTOCHROME P450 2C9; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; MULTIDRUG RESISTANCE PROTEIN;

ADULT; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN EXPRESSION; ULCERATIVE COLITIS;

COLORECTAL TISSUES; CROHN'S DISEASE; CYTOCHROME P450; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; CROHN DISEASE; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MIDDLE AGED; TRANSCRIPTOME;

EID: 84896724325     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2013.12.010     Document Type: Article

References (45)

1. Bibi Z. Role of cytochrome P450 in drug interactions. Nutr. Metab. 2008, 5:27.
2. Anzenbacher P., Anzenbacherova E. Cytochromes P450 and metabolism of xenobiotics. CMLS, Cell. Mol. Life Sci. 2001, 58:737-747.
3. Lewis D.F., Lake B.G., Dickins M. Substrates of human cytochromes P450 from families CYP1 and CYP2: analysis of enzyme selectivity and metabolism. Drug Metab. Drug Interact. 2004, 20:111-142.
4. Emoto C., Iwasaki K. Approach to predict the contribution of cytochrome P450 enzymes to drug metabolism in the early drug-discovery stage: the effect of the expression of cytochrome b(5) with recombinant P450 enzymes. Xenobiotica 2007, 37:986-999.
5. Kumarakulasingham M., Rooney P.H., Dundas S.R., Telfer C., Melvin W.T., Curran S., Murray G.I. Cytochrome P450 profile of colorectal cancer: identification of markers of prognosis. Clin. Cancer Res. 2005, 11:3758-3765.
6. Slattery M.L., Samowtiz W., Ma K., Murtaugh M., Sweeney C., Levin T.R., Neuhausen S. CYP1A1, cigarette smoking, and colon and rectal cancer. Am. J. Epidemiol. 2004, 160:842-852.
7. Murtaugh M.A., Sweeney C., Ma K.N., Caan B.J., Slattery M.L. The CYP1A1 genotype may alter the association of meat consumption patterns and preparation with the risk of colorectal cancer in men and women. J. Nutr. 2005, 135:179-186.
8. Bergheim I., Bode C., Parlesak A. Distribution of cytochrome P450 2C, 2E1, 3A4, and 3A5 in human colon mucosa. BMC Clin. Pharmacol. 2005, 5:4.
9. Ding X., Kaminsky L.S. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu. Rev. Pharmacol. Toxicol. 2003, 43:149-173.
10. Kaminsky L.S., Zhang Q.Y. The small intestine as a xenobiotic-metabolizing organ. Drug Metab. Dispos. 2003, 31:1520-1525.
11. Garnier R., Rambourg-Schepens M.O., Muller A., Hallier E. Glutathione transferase activity and the formation of macromolecular adducts in two cases of acute methyl bromide poisoning. Occup. Environ. Med. 1996, 53:211-215.
12. Uetrecht J.P. The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions. Drug Metab. Rev. 1992, 24:299-366.
13. Seidegard J., Ekstrom G. The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. Environ. Health Perspect. 1997, 105(Suppl. 4):791-799.
14. Pavek P., Dworak Z. Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Curr. Drug Metab. 2008, 9:129-143.
15. Ambudkar S.V., Dey S., Hrycyna C.A., Ramachandra M., Pastan I., Gottesman M.M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 1999, 39:361-398.
16. Zhou S.F. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 2008, 38:802-832.
17. Lin J.H., Chiba M., Baillie T.A. Is the role of the small intestine in first-pass metabolism overemphasized?. Pharmacol. Rev. 1999, 51:135-158.
18. Higaki K., Sone M., Ogawara K., Kimura T. Regulation of drug absorption from small intestine by enteric nervous system I: a poorly absorbable drug via passive diffusion. Drug Metab. Pharmacokinet. 2004, 19:198-205.
19. Zhang Y., Benet L.Z. The gut as a barrier to drug absorption: combined role of cytochrome P4503A and P-glycoprotein. Clin. Pharmacokinet. 2001, 40:159-168.
20. Christians U. Transport proteins and intestinal metabolism: P-glycoprotein and cytochrome P4503A. Ther. Drug Monit. 2004, 26:104-106.
21. Lalloo A.K., Luo F.R., Guo A., Paranjpe P.V., Lee S.H., Vyas V., Rubin E., Sinko P.J. Membrane transport of camptothecin: facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2). BMC Med. 2004, 2:16.
22. von Richter O., Burk O., Fromm M.F., Thon K.P., Eichelbaum M., Kivisto K.T. Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens. Clin. Pharmacol. Ther. 2004, 75:172-183.
23. Kivisto K.T., Niemi M., Fromm M.F. Functional interaction of intestinal CYP3A4 and P-glycoprotein. Fundam. Clin. Pharmacol. 2004, 18:621-626.
24. Murray G.I., Barnes T.S., Swell H.F., Ewen S.W., Melvin W.T., Burk M.D. The immunochemical localization and distribution of cytochrome P450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P450. Br. J. Clin. Pharmacol. 1988, 25:465-475.
25. Kolars J.C., Lown K.S., Schmiedlin-Ren P., Ghosh M., Fang C., Wrighton S.A., Merion R.M., Watkins P.B. CYP3A gene expression in human gut epithelium. Pharmacogenetics 1994, 4:247-259.
26. Daly A.K. Significance of the minor cytochrome P450 3A isoforms. Clin. Pharmacokinet. 2006, 45:13-31.
27. Kharasch E.D., Hoffer C., Whittington D., Sheffels P. Role of hepatic and intestinal cytochrome P4503A and 2B6 in the metabolism, disposition, and miotic effects of methadone. Clin. Pharmacol. Ther. 2004, 76:250-269.
28. Kharasch E.D., Whittington D., Hoffer C. Influence of hepatic and intestinal cytochrome P4503A activity on the acute disposition and effects of oral transmucosal fentanyl citrate. Anesthesiology 2004, 101:729-737.
29. Lalovic B., Phillips B., Risler L.L., Howald W., Shen D.D. Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes. Drug Metab. Dispos. 2004, 32:447-454.
30. Kolars J.C., Schmiedlin-Ren P., Schuetz J.D., Fang C., Watkins P.B. Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. J. Clin. Invest. 1992, 90:1874-1878.
31. Wacher V.J., Wu C.Y., Benet L.Z. Overlapping substrate specificities and tissue distribution of cytochrome P4503A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol. Pharmacol. 1995, 13:129-134.
32. Liu Y.T., Hao H.P., Liu C.X., Wang G.J., Xie H.G. Drugs as CYP3A probes, inducers, and inhibitors. Drug Metab. Rev. 2007, 39:699-721.
33. Niwa T., Murayama N., Emoto C., Yamazaki H. Comparison of kinetic parameters for drug oxidation rates and substrate inhibition potential mediated by cytochrome P450 3A4 and 3A5. Curr. Drug Metab. 2008, 9:20-33.
34. Lown K.S., Mayo R.R., Leichtman A.B., Hsiao H.L., Turgeon K., Schmiedlin-Ren P., Brown M.B., Guo W., Rossi S.J., Benet L.Z., Watkins P.B. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin. Pharmacol. Ther. 1997, 62:248-260.
35. Patel J., Mitra A.K. Strategies to overcome simultaneous P-glycoprotein mediated efflux and CYP3A4 mediated metabolism of drugs. Pharmacogenomics 2001, 2:401-415.
36. Pal D., Mitra A.K. MDR- and CYP3A4-mediated drug-drug interactions. J. Neuroimmune Pharmacol. 2006, 1:323-339.
37. De Waziers I., Cugenec P.H., Yang C.S., Lerous J.P., Beaune P.H. Cytochrome P450 isoenzymes, epoxide hydrolase and glutathione transferase in rat and human hepatic and extrahepatic tissues. J. Pharmacol. Exp. Ther. 1990, 253:387-394.
38. Murray G.I., Paterson P.J., Weaver R.J., Ewen S.W., Melvin W.T., Burke M.D. The expression of cytochrome P-450, epoxide hydrolase, and glutathione S-transferase in hepatocellular carcinoma. Cancer 1993, 71:36-43.
39. Lindell M., Lang M., Lennernas H. Expression of genes encoding for drug metabolising cytochrome P450 enzymes and P-glycoprotein in the rat small intestine comparison to the liver. Eur. J. Drug Metab. Pharmacokinet. 2003, 28:41-48.
40. Hakkak R., Korourian S., Ronis M.J., Ingelman-Sundberg M., Badger T.M. Effects of diet and ethanol on the expression and localization of cytochromes P450 2E1 and P450 2C7 in the colon of male rats. Biochem. Pharmacol. 1996, 51:61-69.
41. Kocarek T.A., Zangar R.C., Novak R.F. Post-transcriptional regulation of rat CYP2E1 expression: role of CYP2E1 mRNA untranslated regions in control of translational efficiency and message stability. Arch. Biochem. Biophys. 2000, 376:180-190.
42. Komura H., Iwaki M. Species differences in in vitro and in vivo small intestinal metabolism of CYP3A substrates. J. Pharm. Sci. 2008, 97:1775-1800.
43. Sheehan D., Meade G., Foley V.M., Dowd C.A. Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem. J. 2001, 360:1-16.
44. Eaton D.L., Bammler T.K. Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol. Sci. 1999, 49:156-164.
45. Sprem M., Babic D., Abramic M., Vrhovec I., Skrk J., Milicic D., Ristov A.A., Kalafatic D., Osmak M. Glutathione and glutathione S-transferases as early markers for ovarian carcinomas: case series. Croat. J. Med. 2001, 42:624-629.